ASSOCIATION OF FIB4 SCORE WITH DISEASE PROGRESSION IN REAL-WORLD POPULATIONS DIAGNOSED WITH NAFLD/NASH OR AT RISK OF NASH IN US CLINICAL PRACTICE

被引：0
|
作者：
Lai, Michelle
Broestl, Jeremy
Frick, Andrew
Haubrich, Richard
Koch, Bruce
Milligan, Scott
Natha, Macky
Younossi, Zobair M.
Afdhal, Nezam H.
机构：
来源：
GASTROENTEROLOGY | 2020年 / 158卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Mo1474
引用
收藏
页码：S1416 / S1416
页数：1
相关论文
共 50 条
  • [31] Real-World Implications of the American Gastroenterology Association Nonalcoholic Fatty Liver Disease Clinical Care Pathway in the US Adult Population
    Xu, Xixi
    Alanaeme, Joseph
    Wen, Ying
    Colantonio, Lisandro D.
    Muntner, Paul
    Long, Michelle T.
    GASTROENTEROLOGY, 2023, 164 (04) : 688 - +
  • [32] ASSOCIATION BETWEEN DISEASE SEVERITY AND PATIENT-REPORTED OUTCOMES IN PATIENTS WITH DISCOID LUPUS ERYTHEMATOSUS IN REAL-WORLD CLINICAL PRACTICE
    Hoskin, B.
    Lobosco, S.
    Bell, D.
    Kao, A.
    Hall, S.
    Chen, S. -Y.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 551 - 551
  • [33] A NEW SCORING SYSTEM COMPOSED OF MMP-1, AST/ALT RATIO AND TOTAL METABOLIC SYNDROME SCORE CAN DETECT AT-RISK NASH PATIENTS WITH FIBROSIS STAGE≥2 MORE ACCURATELY THAN FIB-4 SCORE, NAFLD FIBROSIS SCORE, BARD SCORE, APRI SCORE AND MR ELASTOGRAPHY
    Koylu, Bahadir
    Sokmensuer, Cenk
    Keskin, Onur
    HEPATOLOGY, 2021, 74 : 926A - 927A
  • [34] REAL-WORLD EVIDENCE, CLINICAL CHARACTERISTICS, & DISEASE PROGRESSION INSIGHTS FROM A GLOBAL COHORT OF PRIMARY BILIARY CHOLANGITIS PATIENTS DIAGNOSED BETWEEN 2015 AND 2023
    Amato, Gianni
    Thompson, Courtney
    HEPATOLOGY, 2023, 78 : S2069 - S2069
  • [35] Shortcomings of "FIB-4 First" strategy in screening for nonalcoholic fatty liver disease (NAFLD) patients at risk for disease progression in a real life setting: will we be detracting therapeutic opportunities from patients?
    Cappelli, Simone
    Salvati, Antonio
    Petralli, Giovanni
    De Rosa, Laura
    Ricco, Gabriele
    Surace, Lidia
    Colombatto, Piero
    Coco, Barbara
    Romagnoli, Veronica
    Oliveri, Filippo
    Bonino, Ferruccio
    Brunetto, Maurizia
    JOURNAL OF HEPATOLOGY, 2023, 78 : S691 - S691
  • [36] A Real-World Evaluation of Risk Factors for Disease Progression in Patients With Polycythemia Vera (PV): An Analysis From the Prospective Observational Study of Patients With Polycythemia Vera in US Clinical Practices (REVEAL)
    Grunwald, Michael R.
    Zwicker, Jeffrey I.
    Gerds, Aaron T.
    Burke, John M.
    Xue, Zhenyi
    Crowgey, Erin L.
    Carl, Justine
    Feldman, Patricia
    Braunstein, Evan M.
    Oh, Stephen T.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S415 - S416
  • [37] HOSPITALIZATION RATES AND ASSOCIATION WITH SURVIVAL RISK AT BASELINE IN PATIENTS WITH PULMONARY ARTERY HYPERTENSION (PAH) RECEIVING SELEXIPAG IN REAL-WORLD (RW) CLINICAL PRACTICE
    Kim, N.
    Farber, H. W.
    Highland, K.
    Chakinala, M. M.
    Hemnes, A. R.
    Chin, K. M.
    Zhao, C.
    Narayan, V
    McLaughlin, V. V.
    VALUE IN HEALTH, 2020, 23 : S486 - S486
  • [38] Real-world use of the FIB-4 calculator in primary care workflows to screen for advanced non-alcoholic fatty liver disease in a large US health system
    Therapondos, George
    Thomas, Anna
    Dieterich, Douglas T.
    Girgrah, Nigel
    Oravetz, Philip
    JOURNAL OF HEPATOLOGY, 2022, 77 : S432 - S432
  • [39] Substantial comorbidities and rising economic burden in real-world non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH) patients with compensated cirrhosis (CC): A large German claims database study
    Canbay, A.
    Meise, D.
    Haas, J. S.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S32 - S32
  • [40] Identification and Characterization of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis (NAFLD/NASH) Patients with Advanced Liver Fibrosis Identified Using Noninvasive Test (NIT) of Hepatic Fibrosis: Real-World Results of 3,421 Patients
    Younossi, Zobair M.
    Shreay, Sanatan
    Parker, Emily
    Loomba, Rohit
    HEPATOLOGY, 2018, 68 : 614A - 615A
12345